» Articles » PMID: 17070093

Clinicopathological and Immunohistochemical Evaluation of Oral Squamous Cell Carcinoma in Patients with Early Local Recurrence

Overview
Journal Oral Oncol
Publisher Elsevier
Specialty Dentistry
Date 2006 Oct 31
PMID 17070093
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Early local recurrence is one of the main causes of treatment failure after definitive therapy of oral squamous cell carcinoma (OSCC), contributing significantly for the relative low survival rates of this neoplasia. The aim of this study was to investigate the clinical, histological and molecular factors involved in early local recurrence of OSCC, which may lead to better risk assessment in some specific cases. Twenty-seven patients with early recurrent OSCC were matched with 54 patients with the same clinical stage and tumor site but without local recurrence, in a pair-matched study design. All cases were evaluated in relation to the clinicopathological features and immunohistochemical expression of Ki-67, p53, bcl-2, FAS, Erb-B2, beta-catenin, and E-cadherin. The variables associated with ELR were alcohol consumption (p=0.019), treatment performed (p=0.041), and expression of Ki-67 (p=0.028), FAS (p=0.005) and membrane beta-catenin (p=0.026). The multivariate survival analysis (Cox regression) showed that surgery with adjuvant radiotherapy [OR=0.26 (95% CI, 0.1-0.6)] and FAS expression [OR=0.21 (95% CI, 0.1-0.5)] had a significant effect for ELR development. Radiotherapy had no significant impact on patients' overall survival. Therefore, both treatment and molecular characteristics of the tumor seem to be involved in early local recurrence.

Citing Articles

Prognostic and Clinicopathological Significance of the Aberrant Expression of β-Catenin in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Ramos-Garcia P, Gonzalez-Moles M Cancers (Basel). 2022; 14(3).

PMID: 35158747 PMC: 8833491. DOI: 10.3390/cancers14030479.


High ACTN1 Is Associated with Poor Prognosis, and ACTN1 Silencing Suppresses Cell Proliferation and Metastasis in Oral Squamous Cell Carcinoma.

Xie G, Zhao L, Chen Q, Tang D, Chen Q, Lu H Drug Des Devel Ther. 2020; 14:1717-1727.

PMID: 32440097 PMC: 7211328. DOI: 10.2147/DDDT.S244516.


Identification and profiling of microRNAs expressed in oral buccal mucosa squamous cell carcinoma of Chinese hamster.

Xu G, Li L, Wei J, Xiao L, Wang X, Pang W Sci Rep. 2019; 9(1):15616.

PMID: 31666604 PMC: 6821846. DOI: 10.1038/s41598-019-52197-3.


What is the Prognostic Significance of Ki-67 Positivity in Oral Squamous Cell Carcinoma?.

Xie S, Liu Y, Qiao X, Hua R, Wang K, Shan X J Cancer. 2016; 7(7):758-67.

PMID: 27162533 PMC: 4860791. DOI: 10.7150/jca.14214.


Downregulation of miR-221 Inhibits Cell Migration and Invasion through Targeting Methyl-CpG Binding Domain Protein 2 in Human Oral Squamous Cell Carcinoma Cells.

He S, Lai R, Chen D, Yan W, Zhang Z, Liu Z Biomed Res Int. 2016; 2015:751672.

PMID: 26788506 PMC: 4695639. DOI: 10.1155/2015/751672.